The University of Chicago Header Logo

Connection

Philip Hoffman to Topotecan

Back to Details
This is a "connection" page, showing publications Philip Hoffman has written about Topotecan.
Philip Hoffman
Connection Strength
0.035
Topotecan
  1. Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer. J Clin Oncol. 1998 Jun; 16(6):2032-7.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.